These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27442127)

  • 1. Host-Pathogen Coevolution and the Emergence of Broadly Neutralizing Antibodies in Chronic Infections.
    Nourmohammad A; Otwinowski J; Plotkin JB
    PLoS Genet; 2016 Jul; 12(7):e1006171. PubMed ID: 27442127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using High-Throughput Sequencing to Characterize the Development of the Antibody Repertoire During Infections: A Case Study of HIV-1.
    Breden F; Watson CT
    Adv Exp Med Biol; 2017; 1053():245-263. PubMed ID: 29549643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site.
    Li L; Wang XH; Williams C; Volsky B; Steczko O; Seaman MS; Luthra K; Nyambi P; Nadas A; Giudicelli V; Lefranc MP; Zolla-Pazner S; Gorny MK
    Mol Immunol; 2015 Aug; 66(2):364-74. PubMed ID: 25965315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological features associated with the development of broadly neutralizing antibodies to HIV-1.
    Moore PL; Williamson C; Morris L
    Trends Microbiol; 2015 Apr; 23(4):204-11. PubMed ID: 25572881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection.
    Sheng Z; Schramm CA; Connors M; Morris L; Mascola JR; Kwong PD; Shapiro L
    PLoS Comput Biol; 2016 May; 12(5):e1004940. PubMed ID: 27191167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.
    Wu X; Zhang Z; Schramm CA; Joyce MG; Kwon YD; Zhou T; Sheng Z; Zhang B; O'Dell S; McKee K; Georgiev IS; Chuang GY; Longo NS; Lynch RM; Saunders KO; Soto C; Srivatsan S; Yang Y; Bailer RT; Louder MK; ; Mullikin JC; Connors M; Kwong PD; Mascola JR; Shapiro L
    Cell; 2015 Apr; 161(3):470-485. PubMed ID: 25865483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising.
    Luo S; Perelson AS
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11654-9. PubMed ID: 26324897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody B cell responses in HIV-1 infection.
    Mouquet H
    Trends Immunol; 2014 Nov; 35(11):549-61. PubMed ID: 25240985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
    Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
    J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catch Me If You Can--The Race Between HIV and Neutralizing Antibodies.
    Geiß Y; Dietrich U
    AIDS Rev; 2015; 17(2):107-13. PubMed ID: 26035168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
    Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE
    J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing.
    Carter CC; Wagner GA; Hightower GK; Caballero G; Phung P; Richman DD; Pond SL; Smith DM
    Virology; 2015 Jan; 474():34-40. PubMed ID: 25463602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural evolution of broadly neutralizing antibodies.
    Alter G; Barouch DH
    Cell; 2015 Apr; 161(3):427-428. PubMed ID: 25910199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
    Sun Z; Li J; Hu X; Shao Y; Zhang MY
    Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward an antibody-based HIV-1 vaccine.
    Hoxie JA
    Annu Rev Med; 2010; 61():135-52. PubMed ID: 19824826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of monoclonal antibody b12-resistant human immunodeficiency virus type 1 variants during natural infection in the absence of humoral or cellular immune pressure.
    Bunnik EM; van Gils MJ; Lobbrecht MS; Pisas L; Nanlohy NM; van Baarle D; van Nuenen AC; Hessell AJ; Schuitemaker H
    J Gen Virol; 2010 May; 91(Pt 5):1354-64. PubMed ID: 20053822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
    Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
    J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fierce Selection and Interference in B-Cell Repertoire Response to Chronic HIV-1.
    Nourmohammad A; Otwinowski J; Łuksza M; Mora T; Walczak AM
    Mol Biol Evol; 2019 Oct; 36(10):2184-2194. PubMed ID: 31209469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenges of modelling antibody repertoire dynamics in HIV infection.
    Luo S; Perelson AS
    Philos Trans R Soc Lond B Biol Sci; 2015 Sep; 370(1676):. PubMed ID: 26194760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.